Procysbi

Active Ingredient(s): Cysteamine Bitartrate
FDA Approved: * April 30, 2013
Pharm Company: * RAPTOR PHARMA CORP
Category: Urinary System

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Procysbi Overview

Cysteamine is a medication intended for a number of indications, and approved by the FDA to treat cystinosis. It is stable aminothiol, i.e., an organic compound containing both an amine and a thiol functional groups. Cysteamine is a white, water-soluble solid. It is often used as salts of the ammonium derivative [HSCH2CH2NH3]+[1] including the hydrochloride, phosphocysteamine, and bitartrate.[2] Cysteamine molecule is biosynthesized in mammals, including huma...

Read more Procysbi Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Cysteamine

Recent Procysbi Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Cysteamine Bitartrate
  • Capsule: 150mg, 50mg
  • Capsule, Delayed Release: 25mg, 75mg
  • Solution: 0.44%
  • Solution/drops: 0.44%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Procysbi: (4 results)

Sorted by National Drug Code
  • 49663-001 Procysbi 25 mg Enteric Coated Capsule by Raptor Therapeutics Inc.
  • 49663-002 Procysbi 75 mg Enteric Coated Capsule by Raptor Therapeutics Inc.
  • 75987-100 Procysbi 25 mg Oral Capsule, Delayed Release Pellets by Horizon Pharma Inc.
  • 75987-101 Procysbi 75 mg Oral Capsule, Delayed Release Pellets by Horizon Pharma Inc.

Other drugs which contain Cysteamine Bitartrate or a similar ingredient: (3 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 21 March 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA